News Headlines Article

Gottlieb: Insurers must be willing to adopt biosimilars
Modern Healthcare

Insurers must be willing to take a short-term financial loss to get long-term savings from adopting biosimilars, outgoing Food and Drug Administration Commissioner Scott Gottlieb said Tuesday.

There are major commercial obstacles to getting biosimilars onto the market to replace pricey biologics, Gottlieb said at a Brookings Institution event. Even though the FDA has approved 16 biosimilars, very few are on the market. Gottlieb will leave his post as commissioner early next month to spend more time with his family.